Abstract

Evaluate the feasibility, safety and accuracy of a CT-guided robotic assistance for percutaneous needle placement in the liver. Sixty-six fiducials were surgically inserted into the liver of ten swine and used as targets for needle insertions. All CT-scan acquisitions and robotically-assisted needle insertions were coordinated with breath motion using respiratory monitoring. Skin entry and target points were defined on planning CT-scan. Then, robotically-assisted insertions of 17G needles were performed either by experienced interventional radiologists or by a novice. Post-needle insertion CT-scans were acquired to assess accuracy (3D deviation, ie. distance from needle tip to predefined target) and safety. All needle insertions (43/43; median trajectory length = 83 mm (interquartile range [IQR] 72–105 mm) could be performed in one (n = 36) or two (n = 7) attempts (100% feasibility). Blinded evaluation showed an accuracy of 3.5 ± 1.3 mm. Accuracy did not differ between novice and experienced operators (3.7 ± 1.3 versus 3.4 ± 1.2 mm, P = 0.44). Neither trajectory angulation nor trajectory length significantly impacted accuracy. No complications were encountered. Needle insertion using the robotic device was shown feasible, safe and accurate in a swine liver model. Accuracy was influenced neither by the trajectory length nor by trajectory angulations nor by operator’s experience. A prospective human clinical trial is recruiting.

Highlights

  • Evaluate the feasibility, safety and accuracy of a computed tomography (CT)-guided robotic assistance for percutaneous needle placement in the liver

  • US has many limitations compared to contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI): less contrast resolution; difficulty in visualizing deep lesions; shadowing artefacts caused by gas, bone or bowel and increased interoperator ­variability[3]

  • Tumors visible with CT or MRI may be inconspicuous or undetectable with U­ S2. This accounts for a large number of planned percutaneous tumor ablations (PTA) for hepatocellular carcinoma (HCC)[4], and a drift towards palliative therapies in approximately 35% of patients with early stage HCC, as shown in real-life s­ tudies[5,6]

Read more

Summary

Introduction

Safety and accuracy of a CT-guided robotic assistance for percutaneous needle placement in the liver. Needle insertion using the robotic device was shown feasible, safe and accurate in a swine liver model. Tumors visible with CT or MRI may be inconspicuous (insufficient distinction in its echogenicity from surrounding liver tissue) or undetectable (located in an area inaccessible to US) with U­ S2 This accounts for a large number of planned percutaneous tumor ablations (PTA) for hepatocellular carcinoma (HCC)[4], and a drift towards palliative therapies in approximately 35% of patients with early stage HCC, as shown in real-life s­ tudies[5,6]. The accuracy of robotic needle insertion must be evaluated in an animal model before any clinical use

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call